How do I buy Corbus Pharmaceuticals (CRBP) stock?

You can purchase shares of Corbus Pharmaceuticals (NASDAQ:CRBP) through any online brokerage.View our list of the best stock brokerages

Who are Corbus Pharmaceuticals (CRBP) competitors?

Other companies in Corbus Pharmaceuticals’s space includes: Molecular Partners AG (NASDAQ:MOLN), Kalaris Therapeutics Inc (NASDAQ:KLRS), Innate Pharma SA (NASDAQ:IPHA), ProQR Therapeutics NV (NASDAQ:PRQR) and Connect Biopharma Holdings Ltd (NASDAQ:CNTB).

What is the forecast, or price target, for Corbus Pharmaceuticals (CRBP) stock?

Corbus Pharmaceuticals has a consensus price target of $50.10.

What is the current price for Corbus Pharmaceuticals (CRBP)?

The stock price for Corbus Pharmaceuticals (NASDAQ: CRBP) is $8.73 last updated January 23, 2026 at 4:00 PM EST.

Does Corbus Pharmaceuticals (CRBP) pay a dividend?

There are no upcoming dividends for Corbus Pharmaceuticals.

When is Corbus Pharmaceuticals (NASDAQ:CRBP) reporting earnings?

Corbus Pharmaceuticals does not have any upcoming earnings scheduled.

Is Corbus Pharmaceuticals (CRBP) going to split?

There is no upcoming split for Corbus Pharmaceuticals.

What sector and industry does Corbus Pharmaceuticals (CRBP) operate in?

Corbus Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Corbus Pharmaceuticals (CRBP) Stock Price, Quote, News & History

Bulls vs Bears

Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Name

Revenue

Change

Gross

Change

EBITDA

Change

EBIT

Change

Earnings

Change

About

Sector

Health Care

Industry

Biotechnology

Corbus Pharmaceuticals Holdings Inc is a precision oncology company with a diversified portfolio and is committed to helping people defeat serious illness by bringing scientific approaches to well-understood biological pathways. The company's develop...

Comments